Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹27Cr
Chewing Tobacco/Pan Masala
Rev Gr TTM
Revenue Growth TTM
-4.81%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

SINNAR
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -11.1 | -43.8 | -15.8 | -29.2 | -3.1 | 52.3 | -35.6 | 22.3 | -21.0 | -9.9 | 77.1 | -39.9 |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Operating Profit Operating ProfitCr |
| -12.5 | -9.3 | 5.4 | 8.3 | -12.1 | -13.0 | -3.1 | 3.4 | -4.1 | 0.0 | 14.7 | -9.0 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | 2,600.0 | -57.1 | 36.4 | 200.0 | -144.0 | -566.7 | -113.3 | 16.7 | 63.6 | 150.0 | 1,250.0 | -200.0 |
| 19.5 | 3.5 | 10.1 | 5.0 | -8.9 | -10.7 | -2.1 | 4.7 | -4.1 | 5.9 | 13.5 | -7.9 |
| 6.2 | 0.7 | 3.7 | 1.5 | -2.8 | -3.5 | -0.5 | 1.9 | -0.9 | 1.8 | 5.8 | -1.8 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -13.4 | -8.4 | -30.4 | -1.4 | -6.3 | 1.4 | 20.9 | -23.6 | -1.4 | 0.4 |
| 9 | 8 | 8 | 5 | 5 | 5 | 5 | 6 | 5 | 5 | 5 |
Operating Profit Operating ProfitCr |
| 10.4 | 5.8 | 2.6 | 2.9 | 0.3 | -1.9 | -3.2 | -3.2 | -1.6 | -4.1 | 2.7 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| | -98.2 | -3,611.7 | -49.2 | -9.9 | 23.2 | 30.3 | 461.4 | -72.9 | -203.7 | 253.0 |
| 2.1 | 0.1 | -1.8 | -3.7 | -4.2 | -3.4 | -2.4 | 7.0 | 2.5 | -2.6 | 4.0 |
| 10.8 | 0.2 | -7.0 | -10.4 | -5.7 | -4.4 | -3.0 | 11.1 | 3.0 | -3.1 | 4.9 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 |
Current Liabilities Current LiabilitiesCr | 6 | 3 | 3 | 3 | 2 | 4 | 3 | 2 | 1 | 1 | 0 |
Non Current Liabilities Non Current LiabilitiesCr | 2 | 2 | 5 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 11 | 9 | 11 | 9 | 8 | 8 | 9 | 8 | 8 | 8 | 7 |
Non Current Assets Non Current AssetsCr | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 1 | 3 | -2 | 2 | 0 | 3 | -1 | -1 | 4 | -1 |
Investing Cash Flow Investing Cash FlowCr | 0 | 0 | 0 | 0 | 0 | -1 | 1 | 1 | 0 | 0 |
Financing Cash Flow Financing Cash FlowCr | -2 | -3 | 2 | -2 | 0 | -2 | 0 | 0 | 0 | 0 |
|
Free Cash Flow Free Cash FlowCr | 1 | 3 | -2 | 2 | 0 | 3 | -1 | 0 | 4 | -1 |
| 664.3 | 72,323.7 | 1,495.5 | -1,058.3 | -47.0 | -1,562.1 | 613.8 | -173.4 | 3,121.9 | 1,029.7 |
CFO To EBITDA CFO To EBITDA% | 137.8 | 566.3 | -1,016.7 | 1,369.0 | 718.8 | -2,793.1 | 449.8 | 378.7 | -4,844.6 | 661.6 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 0 | 0 | 9 | 0 | 0 | 9 | 19 | 29 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 19.5 | 155.2 | 0.0 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.0 | 0.0 | 1.6 | 0.0 | 0.0 | 1.4 | 3.9 | 6.2 |
Price To Book Price To Book | 0.0 | 0.0 | 0.0 | 0.0 | 2.1 | 0.0 | 0.0 | 2.0 | 4.1 | 6.6 |
| 3.6 | 2.5 | 17.2 | 10.3 | 693.7 | 0.7 | 0.4 | -42.3 | -188.1 | -135.8 |
Profitability Ratios Profitability Ratios |
| 27.5 | 23.8 | 25.8 | 36.0 | 34.4 | 23.7 | 27.5 | 27.4 | 28.2 | 32.0 |
| 10.4 | 5.8 | 2.6 | 2.9 | 0.3 | -1.9 | -3.2 | -3.2 | -1.6 | -4.1 |
| 2.1 | 0.1 | -1.8 | -3.7 | -4.2 | -3.4 | -2.4 | 7.0 | 2.5 | -2.6 |
| 10.8 | 7.8 | 2.2 | 2.0 | -0.2 | -2.5 | -3.3 | 10.9 | 4.5 | -3.2 |
| 4.7 | 0.1 | -3.0 | -4.7 | -5.5 | -4.4 | -3.2 | 10.2 | 2.7 | -2.8 |
| 1.7 | 0.0 | -1.1 | -2.1 | -2.5 | -1.7 | -1.2 | 4.7 | 1.4 | -1.4 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Sinnar Bidi Udyog Limited is an Indian-domiciled entity historically rooted in the tobacco industry. The company is currently navigating a significant strategic pivot, transitioning from an active manufacturing and trading operation toward a holding and investment-focused structure, while simultaneously pursuing a voluntary delisting from the **BSE Limited**.
---
### **Strategic Transition: Voluntary Delisting & Private Consolidation**
The company is currently undergoing a formal **Voluntary Delisting** process initiated by its promoters to consolidate ownership and exit the public markets.
* **Rationale for Delisting:** The promoters (**Acquirers**) aim to obtain **100%** control to enhance **operational flexibility**. This move is intended to eliminate the high costs of regulatory compliance, listing fees, and administrative burdens associated with being a listed entity, allowing management to focus on business operations rather than stock exchange requirements.
* **The Offer Terms:** In **June 2024**, the company received an **Initial Public Announcement (IPA)**. The **Floor Price** has been set at **₹ 335/-** per Equity Share (Face Value **₹ 5/-**).
* **Key Stakeholders:** The primary **Acquirers** are **Rasbihari Enterprises Private Limited** and **Mr. Shrirang Kisanlal Sarda**. **Vivro Financial Services Private Limited** is acting as the Manager to the Offer.
* **Success Criteria:** Under **SEBI (Delisting of Equity Shares) Regulations, 2021**, the delisting is successful only if the promoters' shareholding reaches a **90%** threshold and a Special Resolution is passed where votes in favor are at least **2x** the votes against.
---
### **Core Business Operations & Market Challenges**
The company’s business model is centralized under a single vertical: the **Manufacturing, Trading, and Processing** of tobacco and tobacco products.
* **Revenue & Profitability Pressures:** The company has experienced a consistent **decrease** in sales turnover across **FY 2023-24** and **FY 2024-25**. Profitability is severely constrained by rising **tobacco costs**, leading to recurring operational losses.
* **Asset-Dependent Earnings:** In recent years, net profits have been largely artificial, supported by the **sale of fixed assets** rather than core tobacco processing activities.
* **Regulatory Barriers:** Management identifies **stringent government regulations** as the primary obstacle to expansion. Consequently, the Board has recommended **no dividend** for the last three financial years to conserve capital.
* **Geographic Footprint:**
* **Registered Office:** Recently relocated to **Andheri, Mumbai** (Office No 804, Mahal Industrial Estate).
* **Administrative Office:** Maintained at **"Camel House"**, Nashik-Pune Road, Nashik.
---
### **Financial Position & Capital Structure**
Sinnar Bidi Udyog operates with a lean capital base, qualifying for specific exemptions under **SEBI (LODR) Regulation 15 (2)** due to its low paid-up capital.
| Metric | FY 2024-25 (As of 31.03.2025) | FY 2023-24 (As of 31.03.2024) |
| :--- | :--- | :--- |
| **Paid-up Equity Share Capital** | **₹ 20.00 Lakhs** | **₹ 20.00 Lakhs** |
| **Net Worth** | **₹ 4.39 Crore** | - |
| **Share of Profit from Associates** | **₹ 0.13 Lakhs** | **₹ 7.25 Lakhs** |
* **Investment Portfolio:** The company maintains interests in associate companies but has no subsidiaries or joint ventures.
* **Vidarbha Bidi Limited** (Associate)
* **Tip Top Health Zone Private Limited** (Associate)
* **Yogi Ayurvedic Products Private Limited** (Investment via STS Exports amalgamation)
---
### **Legacy Liabilities & Risk Factors**
The company’s financial health is significantly impacted by historical liabilities stemming from past tobacco exports to the United States.
* **US Escrow Deposit Liability:** Under US law, the company must deposit funds into an **Escrow Fund** based on historical tobacco sales. This remains a major provision on the balance sheet.
* **Foreign Exchange Exposure:** While there are no active foreign exchange earnings, the company reports **Foreign Exchange Losses** (e.g., **₹ 7.46 Lakhs** in FY25) due to the restatement of the USD-denominated escrow liability.
**Escrow Fund Provisioning Trends:**
| Particulars | March 31, 2025 | March 31, 2024 | March 31, 2023 |
| :--- | :--- | :--- | :--- |
| **Total Provision for Escrow** | **₹ 289.04 Lakhs** | **₹ 281.59 Lakhs** | **₹ 278.15 Lakhs** |
| **FX Loss (Restatement)** | **₹ 7.46 Lakhs** | **₹ 3.43 Lakhs** | **₹ 20.86 Lakhs** |
| **Fresh Demands** | **Nil** | **Nil** | **Nil** |
* **Solvency Concerns:** Auditors have noted that while the company can meet liabilities due within **one year**, there is no long-term assurance regarding **future viability** or the ability to discharge liabilities beyond the immediate **12-month** horizon.
---
### **Governance & Management Framework**
The company adheres to **Indian Accounting Standards (Ind AS)** and maintains a stable leadership team to oversee the delisting and liability management.
* **Key Leadership:**
* **Mr. Ramdas Prabhakar Jadhav:** Re-appointed as **Whole Time Director & CFO** for a three-year term starting **April 1, 2025**.
* **Ms. Aditi Shah:** Appointed as **Additional Director (Independent & Non-Executive)** for a **5-year** term effective **June 1, 2025**.
* **Regulatory Compliance:**
* The company has assessed the **New Labour Codes** (effective **November 21, 2025**) and determined that no additional financial provisions are required at this stage.
* Due to its small size, it is exempt from filing **Annual Secretarial Compliance Reports** and **Regulation 23(9)** related party disclosures.
* **Audit Oversight:** Due diligence for the delisting process is conducted by **M/s. A.K. Jain & Associates** (Peer Review Company Secretary).